Yindan Xinnaotong Soft Capsule Ameliorates Parkinson’s Disease and is Associated with Modulation of the AKT/MDM2/p53 Pathway: Network Pharmacology, Molecular Docking, and Experimental Validation
- DOI
- 10.2174/0118715273512545261019104226
- Published
- 2026-10-22
- Container
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2174/0118715273512545261019104226,
title = {Yindan Xinnaotong Soft Capsule Ameliorates Parkinson’s Disease and is Associated with Modulation of the AKT/MDM2/p53 Pathway: Network
Pharmacology, Molecular Docking, and Experimental Validation},
author = {Yulei Xia and Yifeng Zhang and Xiaolu Wang and Hang Yang and Shuai Hou and Hua Yang and yanqiang wang},
year = {2026},
journal = {CNS \& Neurological Disorders - Drug Targets},
doi = {10.2174/0118715273512545261019104226},
url = {https://doi.org/10.2174/0118715273512545261019104226}
}RIS
TY - JOUR TI - Yindan Xinnaotong Soft Capsule Ameliorates Parkinson’s Disease and is Associated with Modulation of the AKT/MDM2/p53 Pathway: Network Pharmacology, Molecular Docking, and Experimental Validation AU - Yulei Xia AU - Yifeng Zhang AU - Xiaolu Wang AU - Hang Yang AU - Shuai Hou AU - Hua Yang AU - yanqiang wang PY - 2026 JO - CNS & Neurological Disorders - Drug Targets DO - 10.2174/0118715273512545261019104226 UR - https://doi.org/10.2174/0118715273512545261019104226 ER -
APA
Xia, Y., Zhang, Y., Wang, X., Yang, H., Hou, S., Yang, H., & wang, Y. (2026). Yindan Xinnaotong Soft Capsule Ameliorates Parkinson’s Disease and is Associated with Modulation of the AKT/MDM2/p53 Pathway: Network Pharmacology, Molecular Docking, and Experimental Validation. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/0118715273512545261019104226
Source records
- crossref · retrieved 2026-11-04T23:09:44.289Z